Decade Capital Management’s Boston Scientific BSX Stock Holding History

Decade Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$22.6M	Buy	+1,378,016	New	+$23.6M	4.88%	2

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LTI

Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Decade Capital Management's BSX Position: Q3 2015 in Review

Decade Capital Management opened a new position in Boston Scientific (BSX) in Q3 2015: 1,378,016 shares worth $22.6M. The stake represents 4.88% of the portfolio and ranks #2 among its holdings.

480 funds tracked by Wall St. Rank hold BSX as of Q3 2015.

Decade Capital Management held 1,378,016 shares of Boston Scientific worth $22.6M as of Q3 2015.
Boston Scientific was a new Decade Capital Management position in Q3 2015.
Boston Scientific made up 4.88% of Decade Capital Management's portfolio in Q3 2015, its #2 holding.
480 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2015.

Based on Decade Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.